Get the Stockscreener App
11.87
12.40%
-1.68
After Hours:
11.30
-0.57
-4.80%
Kodiak Sciences Inc stock is traded at $11.87, with a volume of 942.26K.
It is down -12.40% in the last 24 hours and up +22.06% over the past month.
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
See More
Previous Close:
$13.55
Open:
$13.4
24h Volume:
942.26K
Relative Volume:
1.23
Market Cap:
$626.99M
Revenue:
-
Net Income/Loss:
$-197.68M
P/E Ratio:
-3.1569
EPS:
-3.76
Net Cash Flow:
$-158.88M
1W Performance:
-21.18%
1M Performance:
+22.06%
6M Performance:
+466.59%
1Y Performance:
+341.26%
1-Day Range:
$11.40
$13.77
1-Week Range:
$11.40
$15.57
52-Week Range:
$1.92
$19.39
Kodiak Sciences Inc Stock (KOD) Company Profile
Name
Kodiak Sciences Inc
Sector
Industry
Phone
650-281-0850
Address
1200 PAGE MILL RD, PALO ALTO, CA
Compare KOD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
11.87 | 715.73M | 0 | -197.68M | -158.88M | -3.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-25-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Sep-22-25 | Initiated | Jefferies | Buy |
| Aug-14-25 | Upgrade | JP Morgan | Underweight → Neutral |
| Dec-09-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-05-24 | Initiated | H.C. Wainwright | Neutral |
| Dec-11-23 | Resumed | Goldman | Sell |
| Nov-17-23 | Upgrade | CapitalOne | Equal Weight → Overweight |
| Jul-27-23 | Downgrade | UBS | Buy → Neutral |
| Jul-25-23 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jul-25-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Jul-24-23 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Jul-24-23 | Downgrade | Jefferies | Buy → Hold |
| Nov-15-22 | Initiated | CapitalOne | Overweight |
| Aug-02-22 | Downgrade | Citigroup | Neutral → Sell |
| Feb-24-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-21 | Upgrade | ROTH Capital | Neutral → Buy |
| Mar-12-21 | Initiated | Evercore ISI | Outperform |
| Mar-01-21 | Downgrade | Barclays | Equal Weight → Underweight |
| Feb-17-21 | Downgrade | ROTH Capital | Buy → Neutral |
| Jan-25-21 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-17-20 | Initiated | Berenberg | Buy |
| Dec-16-20 | Initiated | UBS | Buy |
| Dec-11-20 | Initiated | Citigroup | Neutral |
| Nov-30-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-16-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-13-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-31-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-03-20 | Initiated | Goldman | Buy |
| Feb-18-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-06-20 | Initiated | SunTrust | Buy |
| Jan-08-20 | Initiated | ROTH Capital | Buy |
| Jan-03-20 | Initiated | Jefferies | Buy |
| Dec-24-19 | Initiated | JP Morgan | Overweight |
| Oct-15-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-20-19 | Initiated | Chardan Capital Markets | Buy |
| Oct-29-18 | Initiated | Barclays | Overweight |
| Oct-29-18 | Initiated | BofA/Merrill | Buy |
| Oct-29-18 | Initiated | Morgan Stanley | Overweight |
View All
Kodiak Sciences Inc Stock (KOD) Latest News
Evaluating Kodiak Sciences Inc. with trendline analysisWeekly Trend Recap & High Return Trade Opportunity Guides - newser.com
Is Kodiak Sciences Inc a good long term investmentSwing Trading Ideas & Join a Community of Smart Investors - earlytimes.in
Kodiak Sciences (NASDAQ:KOD) Stock Rating Lowered by Wall Street Zen - Defense World
Kodiak Sciences (NASDAQ:KOD) Trading Down 6.3%Should You Sell? - MarketBeat
How to use a screener to detect Kodiak Sciences Inc. breakoutsMarket Trend Review & Consistent Profit Trading Strategies - newser.com
Published on: 2025-10-10 09:30:52 - newser.com
How geopolitical risks impact Kodiak Sciences Inc. (K27) stock2025 Bull vs Bear & Stock Timing and Entry Methods - newser.com
Can Kodiak Sciences Inc. (K27) stock deliver double digit returnsProduct Launch & Safe Entry Trade Signal Reports - newser.com
Can Kodiak Sciences Inc. (K27) stock attract ESG investmentsPortfolio Risk Summary & Low Risk Entry Point Tips - newser.com
Is Kodiak Sciences Inc. stock poised for growth2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com
FY2025 EPS Estimates for Kodiak Sciences Boosted by Analyst - MarketBeat
Weiss Ratings Reiterates Sell (E+) Rating for Kodiak Sciences (NASDAQ:KOD) - MarketBeat
Top chart patterns to watch in Kodiak Sciences Inc.July 2025 Review & AI Optimized Trade Strategies - newser.com
What makes Kodiak Sciences Inc. (K27) stock appealing to growth investors2025 Technical Patterns & Risk Controlled Daily Trade Plans - newser.com
Will Kodiak Sciences Inc. (K27) stock sustain uptrend momentumJuly 2025 Movers & Safe Capital Growth Trade Ideas - newser.com
Sector ETF performance correlation with Kodiak Sciences Inc.Market Sentiment Review & Safe Capital Allocation Plans - newser.com
Will Kodiak Sciences Inc. (K27) stock keep raising dividendsBull Run & Real-Time Volume Spike Alerts - newser.com
Why Kodiak Sciences Inc. (K27) stock is a strong buy callPortfolio Risk Summary & Accurate Buy Signal Alerts - newser.com
Published on: 2025-10-09 02:49:48 - newser.com
Kodiak Sciences Inc. $KOD Shares Sold by Public Employees Retirement System of Ohio - Defense World
Chardan Capital Maintains Kodiak Sciences (KOD) Neutral Recommendation - Nasdaq
KOD: Chardan Capital Maintains Neutral Rating with $14 Price Tar - GuruFocus
Kodiak Sciences' (KOD) Neutral Rating Reaffirmed at Chardan Capital - MarketBeat
Chardan Sets Price Target on Kodiak Sciences at $14, Maintains Neutral Rating - MarketScreener
What valuation multiples suggest for Kodiak Sciences Inc. stock2025 Technical Overview & Advanced Technical Analysis Signals - newser.com
Kodiak Sciences Inc. (NASDAQ:KOD) Receives $13.00 Consensus Target Price from Brokerages - Defense World
How strong dollar benefits Kodiak Sciences Inc. (K27) stock2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Will Kodiak Sciences Inc. continue its uptrend2025 Key Highlights & High Conviction Investment Ideas - newser.com
What to do if you’re stuck in Kodiak Sciences Inc.2025 Key Highlights & Entry Point Confirmation Alerts - newser.com
Kodiak Sciences Inc. (NASDAQ:KOD) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Why Kodiak Sciences Inc. (K27) stock fits value portfoliosJuly 2025 Update & High Yield Stock Recommendations - newser.com
Full technical analysis of Kodiak Sciences Inc. stockJuly 2025 Pullbacks & Stock Timing and Entry Methods - newser.com
Understanding Kodiak Sciences Inc.’s price movementJuly 2025 PostEarnings & Long Hold Capital Preservation Tips - newser.com
We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate - Yahoo Finance
Kodiak Sciences (NASDAQ:KOD) Shares Gap DownTime to Sell? - MarketBeat
Kodiak Sciences Inc Stock (KOD) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):